Observational Study of Meloxicam in Any Labeled Indication

Completed

• Conditions: Arthritis, Rheumatoid
• Interventions: Drug: Meloxicam

• Registration Number: NCT02182739
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-01
• Primary Completion: 2001-12
• Status Verified: 2014-07
• Study First Submitted: 2014-07-03
• Study First Submitted QC: 2014-07-03
• Study First Posted: 2014-07-08
• Last Update Submitted: 2014-10-28
• Last Update Posted: 2014-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 13039

Inclusion Criteria

• Patients according to the physicians medical criteria on the labeled indications for Meloxicam

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Meloxicam	Meloxicam	-

Primary Outcome Measures

Name	Time	Method
Change in assessment of intensity of pain on a 4-point verbal rating scale	up to 1 year
Assessment of tolerability on a 4-point scale	up to 1 year

Secondary Outcome Measures

Name	Time	Method
Number of patients with adverse events	up to 1 year